[维拉必利对促黄体生成素、促卵泡生成素和催乳素水平及对更年期综合征的影响]
[Effect of veralipride on LH, FSH, and PRL levels and on the climacteric syndrome].
作者信息
De Cecco L, Venturini P L, Alibrandi M P, Grondona A L, Morano S, Penna L, Campanella G, Ragni N
出版信息
Rev Fr Gynecol Obstet. 1985 Feb 28;80(3):152-5.
21 women with menopausal disorders were given veralipride, which is a benzamide derivative having a central anti-dopaminergic action. The LH, FSH and PRL plasma levels were controlled before and after treatment. Treatment, using veralipride at a daily dose of 100 mg for 20 days, improved the climacteric syndrome, and, in particular, the sudden hot flushes. The FSH plasma levels remained unchanged, the LH levels were reduced, although they remained high, and the PRL levels increased during the course of the treatment.
21名患有更年期紊乱的女性服用了维拉必利，这是一种具有中枢抗多巴胺能作用的苯甲酰胺衍生物。在治疗前后对血浆促黄体生成素（LH）、促卵泡生成素（FSH）和催乳素（PRL）水平进行了监测。使用每日剂量100毫克的维拉必利进行治疗，持续20天，改善了更年期综合征，尤其是突然出现的潮热症状。治疗过程中，血浆FSH水平保持不变，LH水平有所降低，尽管仍处于较高水平，PRL水平则升高。
Zotero 插件